Back to Search Start Over

Lung function decline in former smokers and low-intensity current smokers: a secondary data analysis of the NHLBI Pooled Cohorts Study.

Authors :
Oelsner EC
Balte PP
Bhatt SP
Cassano PA
Couper D
Folsom AR
Freedman ND
Jacobs DR Jr
Kalhan R
Mathew AR
Kronmal RA
Loehr LR
London SJ
Newman AB
O'Connor GT
Schwartz JE
Smith LJ
White WB
Yende S
Source :
The Lancet. Respiratory medicine [Lancet Respir Med] 2020 Jan; Vol. 8 (1), pp. 34-44. Date of Electronic Publication: 2019 Oct 09.
Publication Year :
2020

Abstract

Background: Former smokers now outnumber current smokers in many developed countries, and current smokers are smoking fewer cigarettes per day. Some data suggest that lung function decline normalises with smoking cessation; however, mechanistic studies suggest that lung function decline could continue. We hypothesised that former smokers and low-intensity current smokers have accelerated lung function decline compared with never-smokers, including among those without prevalent lung disease.<br />Methods: We used data on six US population-based cohorts included in the NHLBI Pooled Cohort Study. We restricted the sample to participants with valid spirometry at two or more exams. Two cohorts recruited younger adults (≥17 years), two recruited middle-aged and older adults (≥45 years), and two recruited only elderly adults (≥65 years) with examinations done between 1983 and 2014. FEV <subscript>1</subscript> decline in sustained former smokers and current smokers was compared to that of never-smokers by use of mixed models adjusted for sociodemographic and anthropometric factors. Differential FEV <subscript>1</subscript> decline was also evaluated according to duration of smoking cessation and cumulative (number of pack-years) and current (number of cigarettes per day) cigarette consumption.<br />Findings: 25 352 participants (ages 17-93 years) completed 70 228 valid spirometry exams. Over a median follow-up of 7 years (IQR 3-20), FEV <subscript>1</subscript> decline at the median age (57 years) was 31·01 mL per year (95% CI 30·66-31·37) in sustained never-smokers, 34·97 mL per year (34·36-35·57) in former smokers, and 39·92 mL per year (38·92-40·92) in current smokers. With adjustment, former smokers showed an accelerated FEV <subscript>1</subscript> decline of 1·82 mL per year (95% CI 1·24-2·40) compared to never-smokers, which was approximately 20% of the effect estimate for current smokers (9·21 mL per year; 95% CI 8·35-10·08). Compared to never-smokers, accelerated FEV <subscript>1</subscript> decline was observed in former smokers for decades after smoking cessation and in current smokers with low cumulative cigarette consumption (<10 pack-years). With respect to current cigarette consumption, the effect estimate for FEV <subscript>1</subscript> decline in current smokers consuming less than five cigarettes per day (7·65 mL per year; 95% CI 6·21-9·09) was 68% of that in current smokers consuming 30 or more cigarettes per day (11·24 mL per year; 9·86-12·62), and around five times greater than in former smokers (1·57 mL per year; 1·00-2·14). Among participants without prevalent lung disease, associations were attenuated but were consistent with the main results.<br />Interpretation: Former smokers and low-intensity current smokers have accelerated lung function decline compared with never-smokers. These results suggest that all levels of smoking exposure are likely to be associated with lasting and progressive lung damage.<br />Funding: National Institutes of Health, National Heart Lung and Blood Institute, and US Environmental Protection Agency.<br /> (Copyright © 2020 Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
2213-2619
Volume :
8
Issue :
1
Database :
MEDLINE
Journal :
The Lancet. Respiratory medicine
Publication Type :
Academic Journal
Accession number :
31606435
Full Text :
https://doi.org/10.1016/S2213-2600(19)30276-0